Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Short term Debt (2016 - 2023)

Creative Medical Technology Holdings (CELZ) has disclosed Short term Debt for 14 consecutive years, with $14194.0 as the latest value for Q1 2023.

  • On a quarterly basis, Short term Debt changed 0.0% to $14194.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $14194.0, a 0.0% change, with the full-year FY2022 number at $14194.0, changed 0.0% from a year prior.
  • Short term Debt was $14194.0 for Q1 2023 at Creative Medical Technology Holdings, roughly flat from $14194.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $6.8 million in Q4 2019 to a low of $10800.0 in Q1 2019.
  • A 5-year average of $931397.4 and a median of $14194.0 in 2021 define the central range for Short term Debt.
  • Biggest YoY gain for Short term Debt was 23457.04% in 2019; the steepest drop was 99.85% in 2019.
  • Creative Medical Technology Holdings' Short term Debt stood at $6.8 million in 2019, then tumbled by 99.84% to $10800.0 in 2020, then surged by 31.43% to $14194.0 in 2021, then changed by 0.0% to $14194.0 in 2022, then changed by 0.0% to $14194.0 in 2023.
  • Per Business Quant, the three most recent readings for CELZ's Short term Debt are $14194.0 (Q1 2023), $14194.0 (Q4 2022), and $14194.0 (Q3 2022).